Next 10 |
Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) PR Newswire SAN MATEO, Calif. , May 20, 2024 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization...
Talphera to Participate at A.G.P. Virtual Healthcare Conference PR Newswire SAN MATEO, Calif. , May 16, 2024 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of i...
2024-05-14 18:21:10 ET Talphera, Inc. (TLPH) Q1 2024 Earnings Conference Call May 14, 2024 4:30 PM ET Company Participants Raffi Asadorian - Chief Financial Officer Vince Angotti - Chief Executive Officer Pam Palmer - Founder and Chief Medical Officer Confe...
2024-05-14 16:06:16 ET More on AcelRx Pharmaceuticals Talphera, Inc. (TLPH) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on AcelRx Pharmaceuticals Historical earnings data for AcelRx Pharmaceuticals Financial information for AcelRx Pha...
Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update PR Newswire First patients at multiple sites are expected to be enrolled in the NEPHRO CRRT registrational study in Q2 2024 Dr. Shakil Aslam , an expert in renal diseases, includi...
2024-05-13 17:35:36 ET Major earnings expected after the bell on Tuesday include: Oxford Lane Capital Corp. ( OXLC ) Capital Southwest Corporation ( CSWC ) Seadrill Limited ( SDRL ) Nu Holdings Ltd. ( NU ) Canoo ( GOEV ) Read the full articl...
2024-05-13 17:20:01 ET More on AcelRx Pharmaceuticals Talphera, Inc. (TLPH) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on AcelRx Pharmaceuticals Historical earnings data for AcelRx Pharmaceuticals Financial information for AcelRx Pha...
Talphera to Host First Quarter 2024 Financial Results Call and Webcast on Tuesday, May 14, 2024 PR Newswire SAN MATEO, Calif. , May 2, 2024 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and...
2024-03-06 21:48:09 ET Talphera, Inc. (TLPH) Q4 2023 Earnings Conference Call March 06, 2024, 16:30 PM ET Company Participants Raffi Asadorian - Chief Financial Officer Vincent Angotti - Chief Executive Officer Pamela Palmer - Chief Medical Officer and Co-Founder...
2024-03-06 16:33:30 ET More on AcelRx Pharmaceuticals Seeking Alpha’s Quant Rating on AcelRx Pharmaceuticals Historical earnings data for AcelRx Pharmaceuticals Financial information for AcelRx Pharmaceuticals Read the full article on Seeking Alpha ...
News, Short Squeeze, Breakout and More Instantly...
Teliphone Corp Company Name:
TLPH Stock Symbol:
OTCMKTS Market:
Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) PR Newswire SAN MATEO, Calif. , May 20, 2024 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization...
Talphera to Participate at A.G.P. Virtual Healthcare Conference PR Newswire SAN MATEO, Calif. , May 16, 2024 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of i...
Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update PR Newswire First patients at multiple sites are expected to be enrolled in the NEPHRO CRRT registrational study in Q2 2024 Dr. Shakil Aslam , an expert in renal diseases, includi...